NCT00293839View on ClinicalTrials.gov

Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder

PHASE3CompletedINTERVENTIONAL
Enrollment

790

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2002

Conditions
Urinary Incontinence
Interventions
DRUG

oxybutynin chloride

All Listed Sponsors
lead

Alza Corporation, DE, USA

INDUSTRY

NCT00293839 - Efficacy and Tolerability of DITROPAN XL (Oxybutynin Chloride) Versus DETROL LA (Tolterodine Tartrate) in Treatment of Overactive Bladder | Biotech Hunter | Biotech Hunter